Background
Idiopathic intracranial hypertension (IIH) is a syndrome defined by elevated intracranial hypertension without radiographic evidence of a mass lesion in the brain. 1 The currently accepted standard of care for medically refractory IIH patients is a cerebrospinal flow diversion procedure (lumboperitoneal (LP) shunt, ventriculoperitoneal (VP) shunts or optic nerve sheath fenestration (ONSF)). 2, 3 ONSF is a procedure usually performed by an ophthalmologist, whereby a slit is made in the optic nerve sheath to reduce the local pressure around the optic nerve, usually a first-line treatment for patients with acute visual loss symptoms rather than headaches. 3 Dural venous sinus stenosis has been increasingly recognized as a treatable cause of elevated intracranial pressure, and DVSS is increasingly performed. 4, 5 We present a single-center retrospective review of all patients who underwent DVSS for IIH.
Methods
Institutional review board (IRB) approval was obtained for a retrospective chart review. A singlecenter retrospective analysis of all consecutive patients undergoing DVSS for IIH at the Medical University of South Carolina (MUSC) from November 2009 to July 2014 was performed. Initially, only patients who were deemed medically refractory by a referring neurologist underwent stenting. Medically refractory patients all underwent lumbar puncture. Lumbar puncture confirmed elevated opening pressures and normal cerebrospinal fluid (CSF) analysis. Towards the mid-point of our experience at MUSC, any patients with a stenosis on direct venography with a significant gradient across the stenosis were treated with stenting prior to surgical CSF flow diversion (CSFFD). Data for presenting symptoms, baseline patient demographics, presence of headache (HA), visual changes, Diamox dose, location of stenosis and pressure gradient were obtained by manual chart review.
Procedure
All patients considered for DVSS had previously undergone non-invasive evaluation with either magnetic resonance venography (MRV) or computed tomographic (CT) venography. Patients with medically refractory IIH, absence of deep venous sinus thrombosis, and venous stenosis on non-invasive imaging were referred for diagnostic venography.
Diagnostic venography
If an appropriate stenosis was identified on non-invasive imaging, all patients underwent diagnostic angiography and venography under local anesthesia. Neither conscious sedation nor endotracheal anesthesia was used, as both of these could decrease the patient's blood pressure and could potentially change the venous pressure gradient across the stenosis.
Arterial and venous femoral access was obtained using bilateral groins to minimize risk of arteriovenous fistula. Arterial angiography was performed using a 5 fr. Diagnostic catheter and was used to evaluate flow dynamics and to perform an indirect venogram, which was used for guide catheter and microcatheter navigation (Boston Scientific Renegade, Natick, MA, USA Hi-Flo 3.2 F microcatheter over a Boston Scientific Fathom 0.016 in microwire) into the superior sagittal sinus. Direct dural sinus pressure measurements were performed at the superior sagittal sinus, transverse sinus, sigmoid sinus and jugular bulb. Direct venography also excluded the presence of deep venous sinus thrombosis.
Based on the available literature 5 
Dural venous sinus stenting technique
Patients with medically refractory IIH with dural sinus stenosis and a pressure gradient of 8 mmHg were offered DVSS. All DVSS procedures were performed under general anesthesia. Via common femoral vein access, a guiding catheter, generally Neuron Max 088 (Penumbra Inc., Alameda, CA, USA), was navigated into the proximal internal jugular vein. In some cases, a Renegade HiFlo catheter was advanced into the superior sagittal sinus and direct sinus pressure measurements were obtained. Using a conduit technique, 6 either the Neuron Max was advanced coaxially over a 6F diagnostic insert (Penumbra Inc.) or a tri-axial system composed of an 038 wire, 5F diagnostic catheter, 6F neuron 070 guiding catheter (or 071 Chaperone guide catheter (Microvention Inc., Tustin, CA, USA)) ( Figure 1 ) and Neuron max catheter were used to cross the stenosis ( Figure 2 ), generally at the transverse-sigmoid junction, and either the Neuron Max or the 070 guide catheter was left across the stenosis. With this large stable access platform, a self-expanding carotid stent (Cordis Precise ProRx (Codman Neurovascular, Raynham, MA, USA)) was advanced through the guide catheter across the stenosis. The Neuron Max was then gently withdrawn proximally ( Figure 3 ) and the stent delivered using standard technique across the stenosis (Figure 4 ). Follow-up venography and pressure measurement were performed to confirm both morphological and hemodynamic resolution of the stenosis. If a there was a persistent stenosis, angioplasty was performed. 
Results
There were 43 patients included in this study, of whom 90.7% were female and 48.8% were African American (the remainder were Caucasian). The mean body mass index (BMI) was 34.8 kg/m 2 (range 21-56 kg/m 2 ) and age was 34.9 years (21-54 years). The follow-up period was 13.5 months (range 1-63 months) ( Table 1) . DVSS was performed as the first procedure for medically refractory IIH in 81.4% (35/43 cases). DVSS was performed in 18.6%, or 8 of 43 patients, who had previously undergone a surgical procedure ( Table 2 ). Half of these prior procedures were ONSF and half were CSFFD procedures.
Headache was a presenting symptom in 100% of patients. On ophthalmologic examination, papilledema was present in 65%, visual acuity changes present in 88.4%, and visual field changes present in 37.2% of patients.
Post procedure, improvement was defined by the improvement in the presenting symptoms, including headache, papilledema, visual acuity and visual field. After intervention, headache improved in 69.2% and remained stable in 30.8%. Although no patient had documented worsening headaches, data was unavailable for four patients. Papilledema improved in 59% of patients (13/22 cases). Visual acuity changes improved in 43% (15/35 cases) and remained the same in 51% (18/35 cases) after treatment. Acuity worsened in only 6% (2/35 cases). Visual field improved in 46% (6/13 cases), stayed the same in another 46% (6/13 cases), and worsened in 8% (1/13 cases) of the patients after treatment.
Opening pressure was only documented in 18 patients, but the mean was 35.8 mmHg (range 14-56 mmHg). The mean pre-stent pressure gradient was 16.74 mmHg (range 7-46 mmHg), but data was not reported for four patients. Patient 37 was reported as >20 mmHg, and for calculation consistency we assumed this to be 20 mmHg. Sixty-nine percent (29/42) of patients had right transverse sinus stenosis, 
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Interventional Neuroradiology 23(2) 28.6% (12/42) had left transverse sinus stenosis, and 2.4% had bilateral stenosis. Ninety-three percent (40/43) of the stents were placed in the right transverse sinus junction, 4.7% (two) stents were placed in the superior sagittal sinus alone, and one patient had two stents placed (superior sagittal sinus and right transverse dural venous sinus). Mean time to angiographic follow-up was 6.5 months, with a range of 0-22 months. A second angiographic follow-up was done for selected patients (patient 15 (8 months) and patient 23 (6 months)). There was a stent patency rate of 81.8% for 9/11 patients and an 18.2% re-stenosis rate. Data was not available for 32 patients because routine follow-up venography was not performed. Repeat stenting was performed in two patients (patients 25 and 30) for in-stent stenosis. Patient 32 had recurrent stenosis but a pressure gradient of only 7 mmHg, and elected not to have additional stent placement.
There was a 100% technical success rate with zero major and minor complications.
Discussion
IIH is a syndrome of exclusion and is currently defined by the Dandy criteria, which include an abnormal elevation of intracranial pressure with a normal composition of CSF and no intracranial mass or venous sinus thrombosis. 1 Pseudotumor cerebri was first described by Quinke in 1893. 7, 8 The classic clinical triad was headache, blurred vision and vomiting. Papilledema was present in approximately 95% of patients, and if left untreated could progress to optic atrophy and irreversible blindness in a subset of patients. 9, 10 The pathophysiology of IIH has been attributed to either overproduction of CSF or decreased absorption of CSF. Some early hypotheses for IIH included serous meningitis (Quinke); increased CSF in the subarachnoid space (Passot); hydrocephalus due to remote effects of bacterial toxins or otitis media (Warrington); and altered vasomotor control of the intracranial bed (Dandy). 11 In a subset of patients, increased intracranial pressure may be due to a focal stenosis in a dural venous sinus. Since CSF is normally absorbed by the pressure-sensitive arachnoid granulations, a stenosis of any sinus may lead to impaired venous drainage, resulting in decreased cerebral venous drainage, which ultimately results in cerebral venous hypertension and impaired CSF reabsorption. 3, 4, 12, 13 However, the causal relationship between dural venous sinus stenosis and IIH is not well understood and may be more complex than simple mechanical flow impairment. Dural venous sinus stenosis in the setting of IIH may represent a common presentation of a heterogeneous group of underlying pathologies.
Several series document resolution of transverse sinus stenosis (in the setting of IIH) after CSFFD with VP shunt placement. [14] [15] [16] In 2006, Scoffings et al. 17 described a patient with IIH on diuretics and acetazolamide who underwent catheter-based venography and direct pressure measurements across a transverse sinus stenosis with a gradient of 19 mmHg (29 to 10 mmHg). After a high volume tap, 45 ml CSF, the pressure decreased from 29 mmHg to 2 mmHg. 17 Immediately following LP shunt , repeat catheterbased venography and direct pressure measurements demonstrated resolution of stenosis and the pressure gradient. 17 The transverse sinus pressures were 7 mmHg. 17 Although the patient had symptomatic improvement for 2 weeks, she ultimately required CSFFD with VP shunt, with symptomatic relief at 1 year follow-up. 17 Indications for surgical intervention included progressive visual symptoms or intractable symptoms, usually headaches. 3, 18, 19 ONSF is considered the first-line treatment if patients have visual symptoms with minimal headaches. 2, 3, [20] [21] [22] [23] [24] ONSF makes logical sense in this subset, because the procedure rapidly reduces pressure on the optic nerve. Limitations of the procedure include patients presenting with severe headaches as primary symptom, availability of ophthalmologists who are comfortable with performing this technically challenging procedure, and recovery, which is not trivial.
CSF diversion techniques (VP or LP shunts) are usually the first surgical intervention for medically refractory patients with IIH. 3, 21, 25, 26 The most common indication is severe headache, but it may be more urgent if the patient presents with progressive visual changes. 2, 19, 25, 27, 28 There are no prospective randomized studies for CSFFD, although previously there was no need for one, given no other readily available option. Until recently, CSFFD was the only option available for this patient population. CSF diversion is an invasive procedure with high rates of revisions. 21, [26] [27] [28] Given the fact that most patients with IIH are young, obese women, the long-term cost of repeat procedures and complications should not be taken lightly. Serious complications described in the literature include shunt infections, 21, [25] [26] [27] [29] [30] [31] [32] tonsillar herniation, 30 subdural hematoma, 31 and CSF fistula. 21 We were uncertain about the severity of ''operative complications,'' as they were not clearly described by Rosenberg et al., 26 so we included them in the minor complications category.
The authors would argue that CSFFD as the universal first-line intervention should be re-evaluated given the high technical and clinical success rates with low complication rate associated with DVSS in appropriately selected patients. We would suggest that all patients being considered for either CSFFD or ONSF for medically refractory IIH should undergo a contrastenhanced MR venogram to exclude the presence of high-grade dural venous sinus stenosis. If present, diagnostic venography with pressure measurements should be performed to verify that the lesion is amenable to DVSS. Then, after review by a multidisciplinary team comprised of neurologists and specialists in ONSF, CSFFD and DVSS, an individualized treatment plan should be established for each patient. Given the fact that none of the procedures has a permanent 100% clinical and technical success rate, treatment failures for one procedure may be amenable to a different procedure. Currently, DVSS is not widely recognized as a potential treatment option for either first-or second-line treatment in this patient population.
Given the relatively small number of patients with medically refractory IIH requiring DVSS, a large randomized study may never be successfully performed. The strongest level of evidence for DVSS may be limited to Class III evidence; therefore, we would urge anyone performing these procedures to carefully collect pre-and post-procedural data (especially ophthalmological data) with long-term follow up and to share that data with the interventional community. This collective data may be pooled in future meta-analysis studies.
Limitations
This was a retrospective review; therefore, major limitations were related to inconsistent data collection and long-term clinical and imaging follow-up. There were inconsistent pre-procedural ophthalmological exams documenting baseline visual acuity and visual field changes. There was also a variable duration of follow-up, generally limited to patients re-presenting with new clinical symptoms. Follow-up imaging was not available in 32/45 patients (71.1%). Future prospective IRB-approved studies may benefit from routine clinical follow-up documenting symptoms and ophthalmologic exams with imaging follow-up (CT venography at 1, 3 and 5 years). CT venography would further clarify rates of in-stent stenosis, stenosis at the proximal or distal margins of the stent, and patency.
Conclusion
Based on our single-center retrospective analysis, DVSS can be performed with high technical success and low complication rates. A majority of patients presented primarily with headache, and these patients had excellent symptom relief with DVSS alone as the first-line treatment for medically refractory IIH. Patients presenting with visual symptoms had lower success rates, and this population should be carefully followed to ensure that alternative treatment with ONSF or VP shunting is pursued when appropriate.
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